| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.340 | 6.488 | 6.490 | 5.492 | 13.473 | 24.346 | 19.219 | 35.164 | 37.779 | 31.142 |
| Total Income - EUR | 8.340 | 6.488 | 6.490 | 5.492 | 13.473 | 24.346 | 19.219 | 35.164 | 37.779 | 31.142 |
| Total Expenses - EUR | 7.931 | 6.617 | 7.759 | 6.571 | 10.197 | 18.324 | 15.335 | 27.966 | 29.476 | 24.461 |
| Gross Profit/Loss - EUR | 409 | -129 | -1.269 | -1.079 | 3.276 | 6.023 | 3.884 | 7.198 | 8.303 | 6.682 |
| Net Profit/Loss - EUR | 159 | -324 | -1.441 | -1.244 | 2.888 | 5.292 | 3.307 | 6.325 | 6.975 | 5.612 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Punct Farmaceutic Veterinar Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 865 | 857 | 842 | 0 | 0 | 0 | 0 | 9.125 | 8.636 | 8.168 |
| Current Assets | 3.066 | 3.001 | 1.891 | 1.927 | 5.652 | 6.722 | 9.820 | 7.419 | 15.289 | 20.108 |
| Inventories | 1.519 | 905 | 919 | 1.882 | 5.155 | 4.565 | 6.800 | 4.918 | 5.497 | 9.182 |
| Receivables | 1.350 | 1.336 | 876 | 0 | 0 | 0 | 0 | 0 | 0 | 208 |
| Cash | 198 | 760 | 96 | 44 | 497 | 2.157 | 3.021 | 2.501 | 9.793 | 10.718 |
| Shareholders Funds | 960 | 627 | -825 | -2.053 | 875 | 6.150 | 9.321 | 15.675 | 22.602 | 28.088 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 2.971 | 3.231 | 3.558 | 3.980 | 4.777 | 572 | 500 | 869 | 1.324 | 188 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Punct Farmaceutic Veterinar Srl